HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ralf Baumann Selected Research

Pruritus (Itching)

8/2012The release of IL-31 and IL-13 after nasal allergen challenge and their relation to nasal symptoms.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ralf Baumann Research Topics

Disease

4Tuberculosis (Tuberculoses)
01/2022 - 01/2008
3Hypersensitivity (Allergy)
01/2021 - 08/2012
2Inflammation (Inflammations)
08/2022 - 02/2016
2Latent Infection
01/2015 - 12/2014
2Allergic Rhinitis
07/2013 - 08/2012
1Cardiovascular Diseases (Cardiovascular Disease)
08/2022
1Respiratory Tract Diseases (Respiratory Tract Disease)
06/2017
1AIDS-Related Complex (ARC)
08/2015
1Seasonal Allergic Rhinitis (Hay Fever)
07/2013
1Eosinophilia
07/2013
1Rhinorrhea
08/2012
1Sneezing
08/2012
1Pruritus (Itching)
08/2012
1Infections
01/2008
1Communicable Diseases (Infectious Diseases)
12/2003

Drug/Important Bio-Agent (IBA)

3CytokinesIBA
01/2022 - 12/2003
3Mycobacterium tuberculosis antigensIBA
01/2022 - 12/2014
2ZincIBA
08/2022 - 02/2016
2CopperIBA
08/2022 - 02/2016
2Proteins (Proteins, Gene)FDA Link
01/2022 - 06/2017
2C-Reactive ProteinIBA
02/2016 - 08/2015
2AllergensIBA
07/2013 - 08/2012
2Interleukin-4 (Interleukin 4)IBA
07/2013 - 01/2008
1AntibodiesIBA
01/2022
1Biomarkers (Surrogate Marker)IBA
01/2021
1Immunoglobulin G (IgG)IBA
06/2017
1Immunoglobulin M (IgM)IBA
06/2017
1Immunoglobulin A (IgA)IBA
06/2017
1AntigensIBA
06/2017
1Endothelin-1 (Endothelin 1)IBA
08/2015
1MetalsIBA
08/2015
1Chemokine CCL26IBA
07/2013
1Interleukin-10 (Interleukin 10)IBA
07/2013
1Interleukin-17 (Interleukin 17)IBA
07/2013
1Interleukin-13IBA
08/2012

Therapy/Procedure

1Therapeutics
03/2013